Sirs: Dyspnoea is a common complaint of about 75% of healthy women during late pregnancy [1] which in many cases is not clinically relevant. However, asthma is the most common medical condition to complicate pregnancy, with episodes of severe exacerbation reported in about 10% of the women with history of asthma [2]. Moreover, 0.5–2% of all pregnancies in Western countries are also complicated by cardiovascular disease and clinical differentiation might be challenging. Cardiomyopathies are rare diseases but are thought to be the main cardiac cause for maternal mortality during pregnancy [3]. A 31-year-old woman who was regularly attending our pneumology outpatient clinic for asthma underwent routine cardiac evaluation in summer 2010 with normal findings on echocardiography examination and a NT-pro-BNP concentration of 76 pg/ml. In February 2011, the now pregnant woman (34th week of pregnancy) was introduced for pneumological consultancy with suspected exacerbation of the known asthma. The asthma was well controlled during the pregnancy so far with rare application of the quickrelief inhaler. For the preceding 10 days the patient reported progressive dyspnoea and coughing during day and night times corresponding to NYHA functional class III–IV with severe trouble sleeping and no effect of the short-acting beta agonist inhaler. Additional application of a steroid inhaler for 3 days did not improve symptoms substantially. On physical examination there was no evidence of wheezing, but bilaterally decreased breathing sound throughout basilar lung fields consistent with high diaphragm due to advanced pregnancy. Spirometry showed reduced vital capacity (2.1 l, 54% of predicted) and normal FEV1/VC ratio of 80%. Laboratory tests showed a minor proteinuria (0.8 g/24 h), normal liver enzymes and platelet count, no signs of haemolysis, Troponin T \ 0.1 lg/l and a NT-pro-BNP concentration of 1,519 pg/ml. An exacerbation of a hypereosinophilic syndrome by pregnancy was unlikely given a peripheral-blood eosinophilia rate of 0.2%. On echocardiography, the left ventricle was dilated (end-diastolic diameter 61 mm) and left-ventricular systolic function was reduced (ejection fraction 40%) with a moderate mitral-valve regurgitation, increased systolic pulmonary-arterial pressure (55–60 mmHg) and large bilateral pleural effusion (Fig. 1). The pleural effusion was drained subsequently and heart failure treatment was started with furosemide (2 9 40 mg/ day) and metoprolol (1 9 23.75 mg/day). Due to refractory heart failure symptoms and increasing evidence of placenta insufficiency after 3 days of heart failure treatment, a Caesarean section was decided which was well tolerated by the patient and the baby. Six days post section echocardiography showed further decrease of the leftventricular function (EF 25%). Relapsing pleural effusion was drained again and heart failure medication was carefully up-titrated to bisoprolol (1 9 5 mg/day), ramipril (1 9 5 mg/day), torasemide (1 9 20 mg/day) which was paralleled by symptomatic improvement (NYHA II-III). In addition, bromocriptine (2 9 2.5 mg/day) was given to stop lactation. An echocardiography examination 2 months after delivery showed an improvement of left-ventricular function (EF 39%) with only mild mitral-valve regurgitation and no evidence for pulmonary hypertension. Peripartum cardiomyopathy is an idiopathic form of dilated cardiomyopathy characterized by depressed R. Pfister (&) K. F. Frank S. Rosenkranz G. Michels Medizinische Klinik III fur Innere Medizin, Herzzentrum der Universitat zu Koln, Kerpener Str. 62, 50924 Cologne, Germany e-mail: roman.pfister@uk-koeln.de